Three collagen hydrolysate supplements showed dramatically different peptide compositions and pharmacological effects on osteoarthritic cartilage, with some increasing inflammatory markers while none stimulated new collagen production.
Zero products stimulated collagen productionDespite being marketed for joint health, none of the three collagen hydrolysate supplements tested increased collagen biosynthesis in human osteoarthritic cartilage tissue, while some increased inflammatory and cartilage-degrading markers.
What the researchers found
No collagen hydrolysate modulated collagen biosynthesis in human knee cartilage explants — the primary benefit these supplements claim to provide.
The products showed disparate effects: Peptan F 2000 (fish) enhanced the activities of cartilage-degrading aggrecanases ADAMTS4 and ADAMTS5 in vitro, without proteoglycan loss from tissue. Mobiforte (porcine) showed the opposite aggrecanase effect. Mobiforte and Peptan F 5000 elevated IL-6, MMP-1, MMP-3, and MMP-13 in cartilage explants — all markers of inflammation and cartilage destruction — while Peptan F 2000 did not.
Biophysical analysis (MALDI-TOF-MS, NMR, AFM) revealed marked differences in total peptide number and shared peptides between the fish and porcine products.
Why it matters
Collagen hydrolysate supplements are a billion-dollar market, widely promoted for joint health without rigorous regulation. This study reveals that not only do these products vary enormously in their peptide composition, but some may actually increase inflammation and cartilage-degrading enzymes in osteoarthritic tissue. The finding that no product stimulated collagen production directly challenges the core marketing claim of these supplements.
How the study worked
Three commercial collagen hydrolysate products (2 fish-derived, 1 porcine-derived) were characterized using MALDI-TOF mass spectrometry, NMR spectroscopy, and atomic force microscopy. Effects on human osteoarthritic knee cartilage explants were tested using a novel dual radiolabeling procedure for collagen biosynthesis, ELISA for cytokines and MMPs, and in vitro aggrecanase activity assays.
What this study cannot tell us
The study was conducted using human cartilage explants in vitro, which may not fully replicate in vivo conditions. Only three commercial products were tested. The peptide concentrations used may not reflect the levels achieved in joint tissue after oral supplementation. The study does not address whether the observed effects translate to clinical outcomes. Bioavailability of collagen peptides reaching joint tissue after oral consumption is a separate question not addressed here.
How to read the evidence
This is a well-designed in vitro study using human osteoarthritic cartilage explants with sophisticated biochemical characterization. While the experimental evidence is rigorous, the in vitro setting may not fully predict in vivo effects of oral supplementation.
When this study was published
Published in 2017, this study remains relevant as collagen supplement marketing continues to grow. The fundamental finding that products are not interchangeable is an ongoing concern in the nutraceutical field.
The bigger picture
This study highlights a critical problem in the nutraceutical industry: the assumption that all collagen hydrolysate products are equivalent. The dramatic differences in peptide composition and biological effects between products — including potentially harmful inflammatory responses — underscore the need for product-specific testing and better regulation. It also raises broader questions about the evidence base for collagen supplements in joint health.
Questions still open
- Should collagen hydrolysate supplements be required to undergo product-specific safety testing before being marketed for joint health?
- Do the inflammatory effects observed in vitro translate to worsening of osteoarthritis in patients taking these supplements?
- What specific peptides within collagen hydrolysates are responsible for the harmful versus neutral effects?
Common questions
Do collagen supplements actually help arthritic joints?
Are all collagen supplements the same?
Read the original research
Metabolic Response of Human Osteoarthritic Cartilage to Biochemically Characterized Collagen Hydrolysates.
International journal of molecular sciences, 18(1)
Citation
Schadow, Saskia; Simons, Viktor S; Lochnit, Guenter; Kordelle, Jens; Gazova, Zuzana; Siebert, Hans-Christian; Steinmeyer, Juergen. (2017). Metabolic Response of Human Osteoarthritic Cartilage to Biochemically Characterized Collagen Hydrolysates.. International journal of molecular sciences, 18(1). https://doi.org/10.3390/ijms18010207